olmesartan has been researched along with endothelin-1 in 2 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (endothelin-1) | Trials (endothelin-1) | Recent Studies (post-2010) (endothelin-1) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 12,740 | 632 | 3,394 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, NC; Chou, TF; Lee, TM; Lin, MS | 1 |
| He, WY; Lv, QZ; Wei, D | 1 |
1 trial(s) available for olmesartan and endothelin-1
| Article | Year |
|---|---|
Effect of nisoldipine and olmesartan on endothelium-dependent vasodilation in essential hypertensive patients.
Topics: Aged; Anthracenes; Antihypertensive Agents; Arginine; Blood Pressure; C-Reactive Protein; Case-Control Studies; Endothelin-1; Endothelium; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Nisoldipine; Nitric Oxide; Propane; Prostaglandins F; Single-Blind Method; Tetrazoles; Vasodilation | 2012 |
1 other study(ies) available for olmesartan and endothelin-1
| Article | Year |
|---|---|
Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocardial Infarction; Pravastatin; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Ventricular Remodeling | 2006 |